Skip to main content
Year archive

Abattis Bioceuticals Corp. — 2020 filings

All 19 regulatory filings released by Abattis Bioceuticals Corp. (ATTBF) in 2020, sourced directly from the official regulator.

19 Filings
2020 Period
2020 filings (19)
Filing Released Lang
News release - English.pdf
Regulatory Filings
2020-09-01 English
News release - English.pdf
Regulatory Filings
2020-07-28 English
52-109F2R - Certification of refiled interim filings - CFO (E).pdf
Regulatory Filings
2020-07-28 English
52-109F2R - Certification of refiled interim filings - CEO (E).pdf
Regulatory Filings
2020-07-28 English
Interim MD&A (amended) - English.pdf
Management Reports
2020-07-28 English
Cover letter.pdf
Regulatory Filings
2020-07-28 English
52-109F1R - Certification of refiled annual filings - CFO (E).pdf
Regulatory Filings
2020-07-28 English
Cover letter.pdf
Regulatory Filings
2020-07-28 English
52-109F1R - Certification of refiled annual filings - CEO (E).pdf
Regulatory Filings
2020-07-28 English
Cover letter.pdf
Remuneration Information
2020-07-28 English
Annual MD&A (amended) - English.pdf
Management Reports
2020-07-28 English
Cover letter.pdf
Regulatory Filings
2020-07-28 English
Audited annual financial statements (amended) - English.pdf
Audit Report / Information FY 2018
2020-07-28 English
News release - English.pdf
Board/Management Information
2020-06-18 English
News release - English.pdf
Regulatory Filings
2020-06-18 English
News release - English.pdf
Regulatory Filings
2020-05-30 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2020-04-30 English
Annual MD&A - English.pdf
Regulatory Filings
2020-04-30 English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).pdf
Regulatory Filings
2020-04-30 English